1. Baseline biomarker (tau PET) characteristics from TANGO: A phase 2 trial of gosuranemab (BIIB092) in early Alzheimer's disease. (1st February 2022) Authors: Racine, Annie M.; Rajagovindan, Raj; Collins, Jessica A.; Kong, Jessica; Li, Yumeng; O'Gorman, John; Jones, Stephanie; Graham, Danielle; Ratti, Elena; Shulman, Melanie Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline biomarker (tau PET) characteristics from TANGO: A phase 2 trial of gosuranemab (BIIB092) in early Alzheimer's disease. (December 2021) Authors: Racine, Annie M.; Rajagovindan, Raj; Collins, Jessica A.; Kong, Jessica; Li, Yumeng; O'Gorman, John; Jones, Stephanie; Graham, Danielle; Ratti, Elena; Shulman, Melanie Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline characteristics from TANGO: Phase 2 study to evaluate gosuranemab (BIIB092) in patients with early Alzheimer's disease: Human: Improving clinical trial methodology. (7th December 2020) Authors: Ratti, Elena; Kong, Jessica; O'Gorman, John; Rajagovindan, Raj; Racine, Annie; Graham, Danielle; Schrempp, Daniela Ramirez; Viollet, Louis; Jones, Stephanie; Mirabile, Tracy; Walsh, Dominic M.; von Rosenstiel, Philipp; Shulman, Melanie Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exploratory evaluation of 18F‐MK‐6240 tau PET positivity in TANGO phase 2 clinical trial of gosuranemab (BIIB092) in Mild Cognitive Impairment and mild Alzheimer's disease. (20th December 2022) Authors: Racine, Annie M; Collins, Jessica A.; DuBois, Jonathan M; Seibyl, John; Kong, Jessica; Li, Yumeng; O'Gorman, John; Makaretz, Sara J.; Jones, Stephanie; Graham, Danielle; Rajagovindan, Raj; Shulman, Melanie; Haeberlein, Samantha Budd Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. F1‐04‐02: Global Deterioration Scale (GDS) Stage 2: Persons with Subjective Cognitive Impairment (SCI) Only Show Significant Declines in GDS Staging System Measures Over a 2‐Year Interval. (1st July 2016) Authors: Reisberg, Barry; Torossian, Carol; Shulman, Melanie; Monteiro, Isabel; Gauthier, Serge; Shao, Yongzhao Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 3 Page Start: P167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗